Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (5): 874-883. doi: 10.19723/j.issn.1671-167X.2022.05.015

Previous Articles     Next Articles

Genetic distribution in Chinese patients with hereditary peripheral neuropathy

Xiao-xuan LIU1,Xiao-hui DUAN2,Shuo ZHANG1,A-ping SUN1,Ying-shuang ZHANG1,Dong-sheng FAN1,*()   

  1. 1. Department of Neurology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Neurology, China-Japan Friendship Hospital, Beijing 100029, China
  • Received:2022-07-02 Online:2022-10-18 Published:2022-10-14
  • Contact: Dong-sheng FAN E-mail:dsfan@sina.com
  • Supported by:
    Peking University Clinical Medicine Plus X-Youth Scholars Project(PKU2021LCXQ019);Peking University Third Hospital Cohort Study Project(BYSYDL2021007)

RICH HTML

 16   

PDF (PC)

254

Abstract:

Objective: To analyze the distribution characteristics of hereditary peripheral neuropathy (HPN) pathogenic genes in Chinese Han population, and to explore the potential pathogenesis and treatment prospects of HPN and related diseases. Methods: Six hundred and fifty-six index patients with HPN were enrolled in Peking University Third Hospital and China-Japan Friendship Hospital from January 2007 to May 2022. The PMP22 duplication and deletion mutations were screened and validated by multiplex ligation probe amplification technique. The next-generation sequencing gene panel or whole exome sequencing was used, and the suspected genes were validated by Sanger sequencing. Results: Charcot-Marie-Tooth (CMT) accounted for 74.3% (495/666) of the patients with HPN, of whom 69.1% (342/495) were genetically confirmed. The most common genes of CMT were PMP22 duplication, MFN2 and GJB1 mutations, which accounted for 71.3% (244/342) of the patients with genetically confirmed CMT. Hereditary motor neuropathy (HMN) accounted for 16.1% (107/666) of HPN, and 43% (46/107) of HPN was genetically confirmed. The most common genes of HMN were HSPB1, aminoacyl tRNA synthetases and SORD mutations, which accounted for 56.5% (26/46) of the patients with genetically confirmed HMN. Most genes associated with HMN could cause different phenotypes. HMN and CMT shared many genes (e.g. HSPB1, GARS, IGHMBP2). Some genes associated with dHMN-plus shared genes associated with amyotrophic lateral sclerosis (KIF5A, FIG4, DCTN1, SETX, VRK1), hereditary spastic paraplegia (KIF5A, ZFYVE26, BSCL2) and spinal muscular atrophy (MORC2, IGHMBP, DNAJB2), suggesting that HMN was a continuum rather than a distinct entity. Hereditary sensor and autosomal neuropathy (HSAN) accounted for a small proportion of 2.6% (17/666) in HPN. The most common pathogenic gene was SPTLC1 mutation. TTR was the main gene causing hereditary amyloid peripheral neuropathy. The most common types of gene mutations were p.A117S and p.V50M. The symptoms were characterized by late-onset and prominent autonomic nerve involvement. Conclusion: CMT and HMN are the most common diseases of HPN. There is a large overlap between HMN and motor-CMT2 pathogenic genes, and some HMN pathogenic genes overlap with amyotrophic lateral sclerosis, hereditary spastic hemiplegia and spinal muscular atrophy, suggesting that there may be a potential common pathogenic pathway between different diseases.

Key words: Hereditary sensory and motor neuropathy, Genes, China

CLC Number: 

  • R741

Figure 1

Constitute distribution of different types of hereditary peripheral neuropathy CMT, Charcot-Marie-Tooth; HMN, hereditary motor neuropathy; HNPP, hereditary neuropathy with liability to pressure palsies; HSAN, hereditary sensory and autosomal neuropathy; FAP, familiar amyloid neuropathy."

Table 1

Epidemiological data of clinical types of HPN"

Phenotype n (%) Age of onset/years Age of examination/years Disease course/years CMTNS-v2
HPN 666 (100) 24.9±17.6 34.3±17.8 9.0±9.4 11.3±5.3
  CMT 495 (74.3) 24.6±18.0 33.4±17.2 8.7±9.0 12.2±5.6
  HMN 107 (16.1) 25.6±17.0 35.4±18.2 9.4±9.5 8.9±5.0
  HNPP 39 (5.9) 27.6±11.0 32.4±12.2 4.4±2.5 8.4±2.9
  HSAN 17 (2.6) 31.5±11.0 38.4±15.2 10.4±9.5 11.8±9.4
  FAP 7 (1.1) 52 (11-78) 55 (12-83) 5.4±2.5 16.8±9.5
  Refsum 1 25 35 10 16

Figure 2

Sural nerve biopsy in a patient with CMT1A A, the number of normal myelinated nerve fibers is reduced, and some myelin are lost and regenerated, showing a typical "onion" like structure (thin arrow), and occasionally regenerative cluster like structure (thick arrow, semi-thin sections, toluidine blue staining ×200); B, the concentric round collagen layer structure formed by Schwann cell proliferation, namely the "onion" structure (electron micrography). CMT, Charcot-Marie-Tooth."

Figure 3

Genetic distribution of CMT (A) and HMN (B) The number of examples is in the bracket, followed by the percentage. CMT, Charcot-Marie-Tooth; HMN, hereditary motor neuropathy."

Figure 4

Sural nerve biopsy in a patient with HMN A, mild loss of large myelinated fibers, unmyelinated nerves had thinned axons (HE ×40); B, patial loss of large myelinated fibers, some Schwann cells showed swollen cytoplasm and degeneration (electron micrography). HMN, hereditary motor neuropathy."

Figure 5

Sural nerve biopsy in a patient with HNPP A, Part of the fiber myelin sheath is folded and thickened (semi-thin sections, toluidine blue staining ×100); B, Concentric myelin thickening formed a "sausage like" structure, named tomaculum (electron micrography). HMN, hereditary motor neuropathy."

Figure 6

Sural nerve biopsy in a patient with FAP A, homogeneous eosinophilic deposit has been found in sural nerve (arrow, HE staining ×40); B, amyloid deposition (arrow, Congo red staining ×100). FAP, familiar amyloid neuropathy."

Table 2

Multiple disease-causing gene with divergent phenotypes"

Gene CMT1 CMT2 HMN ALS HSP SMA
PMP22 CMT1A, CMT1E, DSS, HNPP
MPZ CMT1B, DSS CMT2J
HSPB1 CMT2F HMN2B
GARS CMT2D HMN5A
IGHMBP2 CMT2S HMN6
HSPB8 CMT2L HMN2A
KIF5A √ √ √
DCTN1 √ √
FIG4 CMT4J √
MORC2 CMT2Z √ √
DYNC1H1 CMT2O √
SPTLC1 HSAN1 √
1 Ghosh S , Tourtellotte WG . The complex clinical and genetic landscape of hereditary peripheral neuropathy[J]. Annu Rev Pathol, 2021, 16, 487- 509.
doi: 10.1146/annurev-pathol-030320-100822
2 Bansagi B , Griffin H , Whittaker RG , et al. Genetic heterogeneity of motor neuropathies[J]. Neurology, 2017, 88 (13): 1226- 1234.
doi: 10.1212/WNL.0000000000003772
3 Rossor AM , Polke JM , Houlden H , et al. Clinical implications of genetic advances in Charcot-Marie-Tooth disease[J]. Nat Rev Neurol, 2013, 9 (10): 562- 571.
doi: 10.1038/nrneurol.2013.179
4 Previtali SC , Zhao E , Lazarevic D , et al. Expanding the spectrum of genes responsible for hereditary motor neuropathies[J]. J Neurol Neurosurg Psychiatry, 2019, 90 (10): 1171- 1179.
doi: 10.1136/jnnp-2019-320717
5 Beijer D , Baets J . The expanding genetic landscape of hereditary motor neuropathies[J]. Brain, 2020, 143 (12): 3540- 3563.
doi: 10.1093/brain/awaa311
6 Klein CJ . Charcot-Marie-Tooth disease and other hereditary neuropathies[J]. Continuum (Minneap Minn), 2020, 26 (5): 1224- 1256.
7 Magy L , Mathis S , Le Masson G , et al. Updating the classification of inherited neuropathies: Results of an international survey[J]. Neurology, 2018, 90 (10): e870- e876.
doi: 10.1212/WNL.0000000000005074
8 Beaudin M , Klein CJ , Rouleau GA , et al. Systematic review of autosomal recessive ataxias and proposal for a classification[J]. Cerebellum Ataxias, 2017, 4, 3.
doi: 10.1186/s40673-017-0061-y
9 Murphy SM , Herrmann DN , McDermott MP , et al. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease[J]. J Peripher Nerv Syst, 2011, 16 (3): 191- 198.
doi: 10.1111/j.1529-8027.2011.00350.x
10 Padilha JPD , Brasil CS , Hoefel AML , et al. Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies[J]. Clin Genet, 2020, 98 (2): 185- 190.
doi: 10.1111/cge.13793
11 Richards S , Aziz N , Bale S , et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17 (5): 405- 424.
doi: 10.1038/gim.2015.30
12 Xie Y , Lin Z , Liu L , et al. Genotype and phenotype distribution of 435 patients with Charcot-Marie-Tooth from central south China[J]. Eur J Neurol, 2021, 28 (11): 3774- 3783.
doi: 10.1111/ene.15024
13 Vaeth S , Christensen R , Dunϕ M , et al. Genetic analysis of Charcot-Marie-Tooth disease in Denmark and the implementation of a next generation sequencing platform[J]. Eur J Med Genet, 2019, 62 (1): 1- 8.
doi: 10.1016/j.ejmg.2018.04.003
14 刘小璇, 孙阿萍, 段晓慧, 等. 中国人群腓骨肌萎缩症的致病基因分布对比研究——14年队列观察[J]. 中华神经科杂志, 2022, 55 (5): 481- 489.
doi: 10.3760/cma.j.cn113694-20211102-00762
15 Cortese A , Zhu Y , Rebelo AP , et al. Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes[J]. Nat Genet, 2020, 2 (5): 473- 481.
16 Sevilla T , Lupo V , Martínez-Rubio D , et al. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease[J]. Brain, 2016, 139 (Pt 1): 62- 72.
17 Liu X , Duan X , Zhang Y , et al. Molecular analysis and clinical diversity of distal hereditary motor neuropathy[J]. Eur J Neurol, 2020, 27 (7): 1319- 1326.
doi: 10.1111/ene.14260
18 Evgrafov OV , Mersiyanova I , Irobi J , et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy[J]. Nat Genet, 2004, 36 (6): 602- 606.
doi: 10.1038/ng1354
19 Antonellis A , Ellsworth RE , Sambuughin N , et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type Ⅴ[J]. Am J Hum Genet, 2003, 72 (5): 1293- 1299.
doi: 10.1086/375039
20 Latour P , Thauvin-Robinet C , Baudelet-Mery C , et al. A major determinant for binding and aminoacylation of tRNA (Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease[J]. Am J Hum Genet, 2010, 86 (1): 77- 82.
doi: 10.1016/j.ajhg.2009.12.005
21 Gonzalez M , McLaughlin H , Houlden H , et al. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2[J]. J Neurol Neurosurg Psychiatry, 2013, 84 (11): 1247- 1249.
doi: 10.1136/jnnp-2013-305049
22 Vester A , Velez-Ruiz G , McLaughlin HM , et al. A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo[J]. Hum Mutat, 2013, 34 (1): 191- 199.
doi: 10.1002/humu.22210
23 Tsai PC , Soong BW , Mademan I , et al. A recurrent WARS mutation is a novel cause of autosomal dominant distal hereditary motor neuropathy[J]. Brain, 2017, 140 (5): 1252- 1266.
doi: 10.1093/brain/awx058
24 Yuan RY , Ye ZL , Zhang XR , et al. Evaluation of SORD mutations as a novel cause of Charcot-Marie-Tooth disease[J]. Ann Clin Transl Neurol, 2021, 8 (1): 266- 270.
doi: 10.1002/acn3.51268
25 Scarlino S , Domi T , Pozzi L , et al. Burden of rare variants in ALS and axonal hereditary neuropathy genes influence survival in ALS: Insights from a next generation sequencing study of an Italian ALS cohort[J]. Int J Mol Sci, 2020, 21 (9): 3346.
doi: 10.3390/ijms21093346
26 Montecchiani C , Pedace L , Giudice TL , et al. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease[J]. Brain, 2016, 139 (Pt 1): 73- 85.
27 Brenner D , Yilmaz R , Muller K , et al. Hot-spot KIF5A mutations cause familial ALS[J]. Brain, 2018, 141 (3): 688- 697.
doi: 10.1093/brain/awx370
28 He J , Liu X , Tang L , et al. Whole-exome sequencing identified novel KIF5A mutations in Chinese patients with amyotrophic lateral sclerosis and Charcot-Marie-Tooth type 2[J]. J Neurol Neurosurg Psychiatry, 2020, 91 (3): 326- 328.
doi: 10.1136/jnnp-2019-320483
29 Stavrou M , Sargiannidou I , Georgiou E , et al. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies[J]. Int J Mol Sci, 2021, 22 (11): 6048.
doi: 10.3390/ijms22116048
30 Bejaoui K , Wu C , Scheffler MD , et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1[J]. Nat Genet, 2001, 27 (3): 261- 262.
doi: 10.1038/85817
31 Eichler FS , Hornemann T , McCampbell A , et al. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1[J]. J Neurosci, 2009, 29 (46): 14646- 14651.
doi: 10.1523/JNEUROSCI.2536-09.2009
32 Fridman V , Suriyanarayanan S , Novak P , et al. Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1[J]. Neurology, 2019, 92 (4): e359- e370.
doi: 10.1212/WNL.0000000000006811
33 Mohassel P , Donkervoort S , Lone MA , et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis[J]. Nat Med, 2021, 27 (7): 1197- 1204.
doi: 10.1038/s41591-021-01346-1
34 Zhang Y , Liu Z , Zhang Y , et al. Corneal sub-basal whorl-like nerve plexus: A landmark for early and follow-up evaluation in transthyretin familial amyloid polyneuropathy[J]. Eur J Neurol, 2021, 28 (2): 630- 638.
doi: 10.1111/ene.14563
35 Buxbaum JN . Oligonucleotide drugs for transthyretin amyloidosis[J]. N Engl J Med, 2018, 379 (1): 82- 85.
doi: 10.1056/NEJMe1805499
36 Visser AC , Klein CJ . Wild-type TTR neuropathy with cardiomyo-pathy presenting with burning feet[J]. Neurology, 2017, 88 (11): 1101- 1102.
doi: 10.1212/WNL.0000000000003721
[1] Ting JING,Hua JIANG,Ting LI,Qianqian SHEN,Lan YE,Yindan ZENG,Wenxin LIANG,Gang FENG,Man-Yau Szeto Ignatius,Yumei ZHANG. Relationship between serum 25-hydroxyvitamin D and handgrip strength in middle-aged and elderly people in five cities of Western China [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 448-455.
[2] Qingbo WANG,Hongqiao FU. Main characteristics and historical evolution of China' s health financing transition [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 462-470.
[3] Huan-rui LIU,Xiang PENG,Sen-lin LI,Xin GOU. Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 793-801.
[4] Jia-hui DENG,Xiao-lin HUANG,Xiao-xing LIU,Jie SUN,Lin LU. The past, present and future of sleep medicine in China [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 567-封三.
[5] Rui-jie CAO,Zhong-qiang YAO,Peng-qing JIAO,Li-gang CUI. Comparison of diagnostic efficacy of different classification criteria for Takayasu arteritis in Chinese patients [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1128-1133.
[6] Zhe LIANG,Fang-fang FAN,Yan ZHANG,Xian-hui QIN,Jian-ping LI,Yong HUO. Rate and characteristics of H-type hypertension in Chinese hypertensive population and comparison with American population [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1028-1037.
[7] Li ZHANG,Ji-fang GONG,Hong-ming PAN,Yu-xian BAI,Tian-shu LIU,Ying CHENG,Ya-chi CHEN,Jia-ying HUANG,Ting-ting XU,Fei-jiao GE,Wan-ling HSU,Jane SHI,Xi-chun HU,Lin SHEN. Atezolizumab therapy in Chinese patients with locally advanced or metastatic solid tumors: An open-label, phase Ⅰ study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 971-980.
[8] Meng-ying WANG,Wen-yong LI,Ren ZHOU,Si-yue WANG,Dong-jing LIU,Hong-chen ZHENG,Zhi-bo ZHOU,Hong-ping ZHU,Tao WU,Yong-hua HU. Association study between haplotypes of WNT signaling pathway genes and nonsyndromic oral clefts among Chinese Han populations [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 394-399.
[9] XU Ying, Ci-ren-yang-jin. Analysis of the relationship between high altitude polycythemia and peptic ulcer bleeding [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 161-165.
[10] DU Wen-yu,YANG Jing-wen,JIANG Ting. Early constant observation of the effect of deferoxamine mesylate on improvement of vascularized bone regeneration in SD rat skull critical size defect model [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1171-1177.
[11] WANG Zhi-cheng,GUO Yan. Association between community socioeconomic status and adults’ self-rated health in China [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 314-319.
[12] HUANG Li-dong,GONG Wei-yu,DONG Yan-mei. Effects of bioactive glass on proliferation, differentiation and angiogenesis of human umbilical vein endothelial cells [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 371-377.
[13] WANG Jing-qi,WANG Xiao. In vivo study of strontium-doped calcium phosphate cement for biological properties [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 378-383.
[14] WU Jun-yi,YU Miao,SUN Shi-chen,FAN Zhuang-zhuang,ZHENG Jing-lei,ZHANG Liu-tao,FENG Hai-lan,LIU Yang,HAN Dong. Detection of EDA gene mutation and phenotypic analysis in patients with hypohidrotic ectodermal dysplasia [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 24-33.
[15] ZHANG Sheng-nan,AN Na,OUYANG Xiang-ying,LIU Ying-jun,WANG Xue-kui. Role of growth arrest-specific protein 6 in migration and osteogenic differentiation of human periodontal ligament cells [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 9-15.
Viewed
Full text
270
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 16 0 0 254

  From Others local
  Times 54 216
  Rate 20% 80%

Abstract
589
Just accepted Online first Issue
0 0 589
  From Others local
  Times 575 14
  Rate 98% 2%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd